Fighting The High Cost Of Rx Drugs

AN INDUSTRY-WIDE TACTIC—At least eight of the top 10 drug makers have paid off their competition to block generics from entering the market. The FTC estimates that pay for delay deals cost consumers and taxpayers $3.5 billion every year in higher drug prices.

It's Time To End Pay For Delay

DRIVING UP THE COST OF RX DRUGS
We all know prescription drugs cost too much. That’s partly because brand-name drug companies have been paying off generic drug makers to delay competition and keep prices high. This practice, called “pay for delay,” is commonplace in the pharmaceutical industry.
 
It's anti-competitive. It's hurting consumers. And it has to stop.

WE PAY THE PRICE
Competition is known to bring drug prices down 85-90 percent:

  • 30-day supply of the cholesterol drug Lipitor costs $194. The generic equivalent? Only $16.
  • The medication needed to prevent blood costs, Plavix, costs $205, while its generic equivalent is $13 for that same 30-day supply.
  • The antibiotic Cipro, used to treat a number of infections, costs $52; the generic costs $7.

And because drug companies can use pay for delay to maintain their strangle hold on the market long after their active-ingredient patents expire, consumers who rely on these drugs for their health are often forced to pay these higher prices for years before they see the generic.

CASE STUDY: Experts expected narcolepsy drug Provigil to go generic in 2006, but pay-for-delay deals kept the generic off the market until 2012. In the meantime, many multiple sclerosis patients had to pay over $1,200 each month for the drug, or manage without it. Bad news for consumers, but good news for the drug company. As the CEO of Cephalon, the drug company that makes Provigil, said about the deal, “We got six more years of patent protection. That’s $4 billion in sales that no one expected.”

TAKING ON BIG PHARMA
Drug companies spend more on lobbying than any other industry. But if we build enough public support, we can stop the industry's pay-for-delay scheme and bring down drug and health care costs for consumers and taxpayers.

We're calling on Congress to put an end to pay for delay once and for all.

Issue updates

Blog Post | Health Care

Here’s that Rx refill you didn’t order

Is your pharmacy refilling your prescription without your knowledge or approval, and billing your insurance company for the cost? If so, it’s the latest example of waste we shouldn't tolerate in our health care system.

> Keep Reading
Media Hit | Health Care

Los Angeles Times: Target, Rite Aid, Walgreens refill drugs without OK, patients say

Some consumers report Target, Rite Aid and Walgreens have refilled their prescription drugs without their approval, similar to allegations involving CVS.

> Keep Reading
News Release | U.S. PIRG | Health Care

Supreme Court Upholds Health Reform

Today’s decision is good news for consumers. Insurance companies can’t go back to the days of dropping your coverage once you become ill, or denying coverage to sick children. And beginning in 2014, the days of insurers being able to deny anyone coverage for “pre-existing conditions” will be history. 

> Keep Reading
News Release | U.S. PIRG | Health Care

Senate Approves S.3187 the Food and Drug Administration Safety and Innovation Act S. 3187

The Senate Passage of the Prescription Drug User Fee Act (PDUFA) not Strong Enough to Ensure Sufficient Consumer Safety from Drugs and Medical devices

> Keep Reading
News Release | U.S. PIRG | Health Care

New Health Exchange Rules Help States Move Forward

The rules released today by the federal Department of Health and Human Services put states in the driver’s seat when it comes to setting up new health benefits exchanges.  

> Keep Reading

Pages

News Release | U.S. PIRG Education Fund | Health Care

New Rules on Insurance Premium Hikes Will Protect Consumers

A statement by U.S. PIRG Health Care Advocate Larry McNeely on regulations released yesterday by the U.S. Department of Health and Human Services regarding the review of unreasonable health insurance premium rate increases.

> Keep Reading
News Release | U.S. PIRG | Health Care

House Bill Would Drive Up Health Costs, Restrict Consumers' Choices

H.R. 1213 would hurt consumers by zeroing out the start-up funds needed to get new competitive state health insurance marketplaces off the ground. Delaying the establishment of these exchanges will mean years more of the status quo – a stagnant marketplace with little competition, fewer choices and unchecked premium growth.

> Keep Reading

Pages

Report | U.S. PIRG | Health Care

Paying for What Works

Congress faces the challenge of transforming macro-level consensus on health care reform into detailed, workable policy. This policy primer is intended to help meet that challenge. It examines seven factors which have led to the interrelated crises in cost and quality, and prescribes specific policy remedies to tame costs and restore health professionals’ ability to provide the care on which American families rely.

> Keep Reading
Report | Illinois PIRG Education Fund | Health Care

Ensuring Accountability

As our economy weakens nationwide, Illinoisans are having a harder time accessing and affording health insurance. Illinois needs to change the way it regulates the health insurance industry to make sure residents have access to predictable and affordable coverage. An analysis conducted by the Illinois Public Interest Research Group indicates that increasing cost-containment and accountability measures for health insurance companies does not mean that the premium costs paid by consumers will increase.

> Keep Reading
Report | U.S. PIRG Education Fund | Health Care

Health Care in Crisis

Unless the new Congress and Administration act to reduce health care costs, the yearly cost of the average employer-paid family health policy in America is projected to more than double from $11,381 in 2006 to $24,291 by 2016 even after adjusting for inflation. If recent trends continue, wages and household incomes will simply not keep up with these high costs.

> Keep Reading
Report | OSPIRG | Health Care

More For Your Money

Oregon businesses and consumers are facing unsustainable increases health insurance premiums and out-of-pocket costs, with health care costs rising at more than double the rate of inflation. Given this, Oregon officials are developing a major health reform plan to cut costs, improve health outcomes, and ensure Oregonians have access to affordable quality health care. The officials charged with this task, the Oregon Health Fund Board, released a draft reform plan for public comment in early September 2008.

> Keep Reading
Report | CALPIRG Education Fund | Health Care

Diagnosing the High Cost of Health Care

California spends billions of health care dollars on unnecessary treatments and services, administrative waste, and overpriced, sometimes harmful, medications. By finding ways to cut waste in its health care system and to reform an incentive structure that encourages overspending, California can reduce the burden that health care costs impose on our economy.

> Keep Reading

Pages

View AllRSS Feed

PRIORITY ACTION

Tell your senator that patients can't afford to wait another day. We need to end "Pay for Delay" right now.

Support Us

Your donation supports U.S. PIRG’s work to stand up for consumers on the issues that matter, especially when powerful interests are blocking progress.

Consumer Alerts

Join our network and stay up to date on our campaigns, get important consumer updates and take action on critical issues.